
Overview
Philosophy of care | My philosophy on care is patient-centered at its core. I see my role as your physician to treat your medical condition but also to take into account other factors that play an important role in the delivery of health care. I hope to work together with you and my fellow team members to accomplish a desired goal and ultimately deliver exceptional medical care to you. | Why I entered medicine | My journey to a career in medicine was a bit roundabout. Initially, I started out with an interest in global health which led me to pursue a dual degree in public health and medicine. This was an attempt to better understand the global factors that play a role in the delivery of health care while studying the pathophysiology of disease. I chose oncology because I found myself drawn to the therapeutic potential of the field. I am excited by the ongoing advances and I look forward to offering these leading-edge treatments to my patients. | Community involvement | As a transplant from Washington, D.C., I look forward to becoming more engaged in local organizations as I start to get to know the area. | Personal interests | My husband and I enjoy hiking with our dog on the weekends and spending time with family and friends.
Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, Paget Disease of the Breast, and Gastrostomy.
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3788 Hecktown Rd, Suite 210, Easton, PA 18045
181 E Brown Street, East Stroudsburg, PA 18301
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Barnabas Health Medical Group PC
Shailja Shah is a Hematologist Oncology specialist and a Hematologist in Newark, New Jersey. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Stomach Cancer, Pleuropulmonary Blastoma, Sickle Cell Disease, Endoscopy, and Colonoscopy.
Atlantic Hematology Oncology
"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.
Temple Faculty Practice Plan Inc
Crystal Denlinger is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Denlinger is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Stomach Cancer, and Fibrolamellar Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Singh isAdvanced. Learn about Breast Cancer.
- Colorectal CancerDr. Singh isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Singh isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Singh isAdvanced. Learn about Familial Prostate Cancer.
- Iron Deficiency AnemiaDr. Singh isAdvanced. Learn about Iron Deficiency Anemia.
- Paget Disease of the BreastDr. Singh isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acquired AgranulocytosisDr. Singh isExperienced. Learn about Acquired Agranulocytosis.
- Acute Mountain SicknessDr. Singh isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Singh isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Singh isExperienced. Learn about Adult Immune Thrombocytopenia.
